Clinica Baviera (Spain) Performance
| CBAV Stock | EUR 35.10 0.50 1.45% |
On a scale of 0 to 100, Clinica Baviera holds a performance score of 12. The firm shows a Beta (market volatility) of -0.45, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Clinica Baviera are expected to decrease at a much lower rate. During the bear market, Clinica Baviera is likely to outperform the market. Please check Clinica Baviera's standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether Clinica Baviera's price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Clinica Baviera are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Clinica Baviera exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 10.8 M | |
| Total Cashflows From Investing Activities | -17.1 M |
Clinica |
Clinica Baviera Relative Risk vs. Return Landscape
If you would invest 3,090 in Clinica Baviera on December 23, 2024 and sell it today you would earn a total of 420.00 from holding Clinica Baviera or generate 13.59% return on investment over 90 days. Clinica Baviera is generating 0.2114% of daily returns and assumes 1.3499% volatility on return distribution over the 90 days horizon. Simply put, 12% of stocks are less volatile than Clinica, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Clinica Baviera Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clinica Baviera's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Clinica Baviera, and traders can use it to determine the average amount a Clinica Baviera's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1566
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CBAV | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.35 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Clinica Baviera is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Clinica Baviera by adding it to a well-diversified portfolio.
Clinica Baviera Fundamentals Growth
Clinica Stock prices reflect investors' perceptions of the future prospects and financial health of Clinica Baviera, and Clinica Baviera fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Clinica Stock performance.
| Return On Equity | 0.47 | |||
| Return On Asset | 0.19 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 301.63 M | |||
| Shares Outstanding | 16.3 M | |||
| Price To Earning | 20.23 X | |||
| Price To Book | 4.33 X | |||
| Price To Sales | 1.50 X | |||
| Revenue | 172.73 M | |||
| EBITDA | 52.91 M | |||
| Cash And Equivalents | 10.79 M | |||
| Cash Per Share | 0.66 X | |||
| Total Debt | 6.52 M | |||
| Debt To Equity | 154.20 % | |||
| Book Value Per Share | 4.27 X | |||
| Cash Flow From Operations | 46.86 M | |||
| Earnings Per Share | 1.82 X | |||
| Total Asset | 133.81 M | |||
About Clinica Baviera Performance
By analyzing Clinica Baviera's fundamental ratios, stakeholders can gain valuable insights into Clinica Baviera's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Clinica Baviera has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Clinica Baviera has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Clnica Baviera, S.A. operates a network of ophthalmological clinics. It operates approximately 80 ophthalmological clinics in Spain, Germany, Austria, and Italy. CLINICA BAVIERA is traded on Madrid SE C.A.T.S. in Spain.Things to note about Clinica Baviera performance evaluation
Checking the ongoing alerts about Clinica Baviera for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Clinica Baviera help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Clinica Baviera has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Clinica Baviera has accumulated 6.52 M in total debt with debt to equity ratio (D/E) of 154.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Clinica Baviera has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Clinica Baviera until it has trouble settling it off, either with new capital or with free cash flow. So, Clinica Baviera's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Clinica Baviera sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Clinica to invest in growth at high rates of return. When we think about Clinica Baviera's use of debt, we should always consider it together with cash and equity. | |
| About 92.0% of Clinica Baviera shares are held by company insiders |
- Analyzing Clinica Baviera's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Clinica Baviera's stock is overvalued or undervalued compared to its peers.
- Examining Clinica Baviera's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Clinica Baviera's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Clinica Baviera's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Clinica Baviera's stock. These opinions can provide insight into Clinica Baviera's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Clinica Stock analysis
When running Clinica Baviera's price analysis, check to measure Clinica Baviera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinica Baviera is operating at the current time. Most of Clinica Baviera's value examination focuses on studying past and present price action to predict the probability of Clinica Baviera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinica Baviera's price. Additionally, you may evaluate how the addition of Clinica Baviera to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |